about
Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulationOxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetesLiving well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancerArachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma.Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia.The risk of Barrett's esophagus associated with abdominal obesity in males and females.Changes in antibiotic distribution due to pancreatitisResveratrol--pills to replace a healthy diet?Clinical review: adiponectin biology and its role in inflammation and critical illness.Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeIdentification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors.Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease.Strengthening the case for global risk assessment of patients with high blood pressure.Changes in serum adiponectin concentrations in critical illness: a preliminary investigation.Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Inflammatory lipid mediators in adipocyte function and obesity.Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience.Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy.Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.Application of an exercise intervention on the evolution of diastolic dysfunction in patients with diabetes mellitus: efficacy and effectiveness.Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease.Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial.Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation.Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage.Tumor necrosis factor-induced cytotoxicity is not related to rates of mitochondrial morphological abnormalities or autophagy-changes that can be mediated by TNFR-I or TNFR-II.Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus.Food, obesity and non-insulin-dependent diabetes: are there molecular links?Postprandial total and HMW adiponectin following a high-fat meal in lean, obese and diabetic men.Reduced phosphorylation of AS160 contributes to glucocorticoid-mediated inhibition of glucose uptake in human and murine adipocytes.Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity.Fibroblast growth factor 1: a key regulator of human adipogenesis.The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes.In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.
P50
Q24310524-1B0321BF-0CDE-45E9-B1CA-A08800876C52Q26860919-F9ABF0EB-4639-49F9-AED1-5F3D2776824DQ28392769-C06C473D-B412-40F7-B544-04136E4F1EBFQ31743193-15E76081-A948-4F0E-8549-C74132CDBDB4Q33509887-636E9C9B-C595-48E0-B7CF-400FE65F6D43Q33517923-68C25F92-78A4-412C-9CC8-07D107AACD8AQ34188091-1D32E54E-314E-407E-A9C2-9EE7922FF935Q34266800-B8BA7C29-0588-4D48-A090-D599579D3651Q35005037-6FD2B2C3-9AD0-440A-B6C5-317069F8F9AAQ35120581-BD405C3D-B3E1-49AE-8095-EFC89F2F9C76Q35559298-1E5600AB-2FDD-4397-B3C3-26E4FC0A08CAQ35594723-81B534EA-2AB7-4342-A535-4DA758359ED4Q35596306-6D45F5E4-7664-4CC2-BCC1-904CA31B8895Q35612446-0CA502C7-30C3-47B6-8222-04D7B1CB42CEQ35856218-AD245A2C-02A6-452F-A339-BC89F2DEBCF5Q37285170-8BBD1B59-9B6B-46D9-876C-491836B59122Q37354830-F203BDB3-E20F-43AE-83A3-7864BDA6CF99Q37360274-B8DFB1BE-4983-4F71-867B-C8AACBAD0AFDQ37376673-E7FF04AA-C107-46A2-A286-0C1219C08ACBQ37410661-3EBDE2D9-DA70-4182-BA3C-1515A78800E2Q37680661-B1F9745F-D4CF-4DE4-BF34-2EDCF5F8E584Q37837059-2DD7AB90-EDA1-4581-9BA5-C74AD303E9F1Q38156703-2B6181F3-DF27-4CA0-873B-35BA3B9B9112Q38337909-7BFBC8F4-B46C-48BF-8FF2-D932A278429AQ38445897-C5DC867E-0B17-4314-9760-1EBB08AAF75FQ38490962-B6125132-62A7-4FD1-95BC-2AC6094F08C7Q38525242-16694B20-A59D-41D2-9BAF-8ED57D12C6A0Q39540648-02C0346D-DD83-4066-A9FC-5D871EB14335Q40215110-9ECCF750-2328-496F-B424-B9E7F3D31D2AQ40939050-D484D494-A3EB-4F39-A59B-B603195D9899Q40950825-8FA38B89-5A27-4688-A0B8-D762A791B679Q40983908-34149E5D-25DB-4D56-836A-1F651269D203Q41713156-B804B07F-0ECA-48CD-B581-F3037BCAFEB3Q42435166-74532CF7-4613-4A13-89E5-12DF1F4D654AQ42445042-9B44ED02-E1BB-4EA1-9E86-AE3FC37F08EBQ42510810-E46DCECF-0EAF-4836-85AF-6E87D5A228CFQ42798251-47D1A80D-25AE-4896-83FD-3CFCFC829218Q42823239-AA824BB4-635C-41C8-B788-16B65F1B87C0Q42976961-CF827128-644D-4B93-BC13-C17264FAED61Q42981587-1DCE95AB-7E91-4D6D-B2BE-3416F3761598
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Johannes B. Prins
@ast
Johannes B. Prins
@en
Johannes B. Prins
@es
Johannes B. Prins
@nl
Johannes B. Prins
@sl
type
label
Johannes B. Prins
@ast
Johannes B. Prins
@en
Johannes B. Prins
@es
Johannes B. Prins
@nl
Johannes B. Prins
@sl
altLabel
John Prins
@en
prefLabel
Johannes B. Prins
@ast
Johannes B. Prins
@en
Johannes B. Prins
@es
Johannes B. Prins
@nl
Johannes B. Prins
@sl
P1053
M-5884-2013
P106
P1153
35450732500
P21
P31
P3829
P496
0000-0001-9497-927X